X Fu, M Liu, S Qu, J Ma, Y Zhang, T Shi, H Wen… - Journal of Experimental …, 2018 - Springer
Background Multidrug resistance is the main obstacle for hepatocellular carcinoma (HCC)
treatment. miR-32-5p is involved in HCC progression but its function in multidrug resistance …